PolyPid to Report Third Quarter 2022 Financial Results and Operational Highlights on November 9, 2022
PETACH TIKVA, Israel, Oct. 26, 2022 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company...
Pharmaceutical
EyePoint Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 2, 2022
WATERTOWN, Mass., Oct. 26, 2022 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and...
XORTX Receives Further No Objection Letter from Health Canada
Amended Bridging Pharmacokinetics Study for Autosomal Dominant Polycystic Kidney Disease – XRx-008 ProgramCALGARY, Alberta, Oct. 26, 2022 (GLOBE NEWSWIRE) --...
Shineco, Inc. to Acquire Controlling Equity Interest in Changzhou Biowin Pharmaceutical Co., Ltd to Step into Point-of-Care Testing Industry
BEIJING, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc.(“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese...
Biora Therapeutics Shares Data from Device Performance Study in Ulcerative Colitis Patients
Data Presented at the ACG Annual Meeting Demonstrates Successful Detection of Colon Entry and Topical Coverage Throughout Portion of Colon...
David S. Smith appointed to the Board of Directors of Predictive Oncology
Leading authority on the therapeutic use of human tissues and cells Director, Predictive Oncology Inc. David S. Smith, JDEAGAN, Minn.,...
Tarsus to Present Additional Saturn-2 Pivotal Phase 3 Trial Data at the American Academy of Optometry 2022 Annual Meeting
Saturn-2 follow-up data to be presented on TP-03 for the treatment of Demodex blepharitis Tarsus recently submitted NDA to the...
Standard BioTools Announces Conference Call and Webcast of Third Quarter 2022 Financial Results
SOUTH SAN FRANCISCO, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – unleashing...
Biopharma Veteran Ivor Macleod Joins SCYNEXIS as Chief Financial Officer
Brings deep industry experience spanning financial and operational roles to support Company and its new strategic directionJERSEY CITY, N.J., Oct....
Catalyst Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 9, 2022
Conference Call and Webcast to be held on November 10, 2022, at 8:30 AM ETCORAL GABLES, Fla., Oct. 25, 2022...
Immix Biopharma to Present Milestones Achieved to Enable Kick-Off of 2 IMX-110 Clinical Trials at the 2022 ThinkEquity Conference on October 26
Immix Biopharma to Present Milestones Achieved to Enable Kick-Off of 2 IMX-110 Clinical Trials at the 2022 ThinkEquity Conference on...
Proteros and Adrestia initiate multi-target partnership to discover first-in-class drugs for intractable genetic diseases
Proteros selected by Adrestia for its cutting-edge structure-based drug discovery engineProteros to support Adrestia in the discovery of first-in-class drugs...
Paratek Pharmaceuticals to Report Third-Quarter 2022 Financial Results on Nov. 3
BOSTON, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the company will host a...
IntelGenx Receives FDA GDUFA Date for Xiromed-Partnered Development Candidate, Buprenorphine Buccal Film
SAINT LAURENT, Quebec, Oct. 25, 2022 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that its...
Intercept to Announce Third Quarter 2022 Financial Results on November 1, 2022
MORRISTOWN, N.J., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and...
CinCor Pharma Announces Presentation of Phase 1 Clinical Data for Baxdrostat at the Upcoming American Society of Nephrology Kidney Week 2022
WALTHAM, Mass., Oct. 25, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC) today announced that the company will present...
Rhythm Pharmaceuticals to Present Full Data from Phase 2 Clinical Trial Evaluating Setmelanotide in Hypothalamic Obesity at ObesityWeek® 2022
-- Rhythm to review data on webcast conference call on November 2, 2022 at 8:30 a.m. ET – -- Rhythm...
Canary Medical Announces Appointment of Lisa Suennen as President, Digital and Data Solutions
VANCOUVER, British Columbia and CARLSBAD, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Canary Medical, a medical data company focused on...
Timber Pharmaceuticals Receives European Orphan Designation for Autosomal Recessive Congenital Ichthyosis & Positive Comments on Pediatric Investigation Plan for TMB-001 in Autosomal Recessive CI & X-Linked Recessive Ichthyosis
- Regulatory Milestones Improve Path to Filing a European Marketing Authorization Application -- Company Plans to Submit Additional Application for...
Biora Therapeutics Shares Five Posters Presented at American College of Gastroenterology Annual Scientific Meeting 2022
Presents Results on Device Performance Studies in Humans for Targeted Therapeutics PlatformSAN DIEGO, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Biora...